Bu‐Nam Jeon

845 total citations
27 papers, 639 citations indexed

About

Bu‐Nam Jeon is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Bu‐Nam Jeon has authored 27 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 12 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Bu‐Nam Jeon's work include Cancer-related Molecular Pathways (7 papers), Ubiquitin and proteasome pathways (3 papers) and Kruppel-like factors research (3 papers). Bu‐Nam Jeon is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), Ubiquitin and proteasome pathways (3 papers) and Kruppel-like factors research (3 papers). Bu‐Nam Jeon collaborates with scholars based in South Korea, United States and Japan. Bu‐Nam Jeon's co-authors include Man‐Wook Hur, Won‐Il Choi, Dong‐In Koh, Choong‐Eun Lee, Hyeonseok Ko, Young‐Joo Kim, Jung‐Yoon Yoo, Ho‐Geun Yoon, Chae‐Ok Yun and Hansoo Park and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Bu‐Nam Jeon

26 papers receiving 633 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bu‐Nam Jeon South Korea 14 453 125 125 111 44 27 639
Kaitlin D. Werle United States 9 386 0.9× 102 0.8× 147 1.2× 49 0.4× 45 1.0× 10 559
Yun Zhou China 16 367 0.8× 80 0.6× 84 0.7× 105 0.9× 18 0.4× 45 632
Jie Han United States 15 527 1.2× 142 1.1× 119 1.0× 176 1.6× 18 0.4× 24 767
Christopher C. Wolford United States 6 289 0.6× 174 1.4× 75 0.6× 125 1.1× 40 0.9× 7 597
Huaxin Zhou China 16 397 0.9× 150 1.2× 151 1.2× 166 1.5× 28 0.6× 42 756
Joost P.M. Melis Netherlands 11 379 0.8× 81 0.6× 153 1.2× 81 0.7× 19 0.4× 13 601
Jui Dutta United States 8 461 1.0× 183 1.5× 215 1.7× 172 1.5× 24 0.5× 14 752
Xiaoming Huang China 14 329 0.7× 119 1.0× 166 1.3× 107 1.0× 48 1.1× 54 616
Jufeng Guo China 17 373 0.8× 204 1.6× 202 1.6× 154 1.4× 27 0.6× 33 673
Blandine Kedjouar France 8 370 0.8× 117 0.9× 120 1.0× 105 0.9× 34 0.8× 8 630

Countries citing papers authored by Bu‐Nam Jeon

Since Specialization
Citations

This map shows the geographic impact of Bu‐Nam Jeon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bu‐Nam Jeon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bu‐Nam Jeon more than expected).

Fields of papers citing papers by Bu‐Nam Jeon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bu‐Nam Jeon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bu‐Nam Jeon. The network helps show where Bu‐Nam Jeon may publish in the future.

Co-authorship network of co-authors of Bu‐Nam Jeon

This figure shows the co-authorship network connecting the top 25 collaborators of Bu‐Nam Jeon. A scholar is included among the top collaborators of Bu‐Nam Jeon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bu‐Nam Jeon. Bu‐Nam Jeon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jeon, Bu‐Nam, et al.. (2023). Abstract 2968: Development of anti-APP antibody targeting APP/CNTN4 axis as a novel cancer immunotherapy. Cancer Research. 83(7_Supplement). 2968–2968.
3.
Yoon, Youngmin, Gihyeon Kim, Bu‐Nam Jeon, Sungsoon Fang, & Hansoo Park. (2021). Bifidobacterium Strain-Specific Enhances the Efficacy of Cancer Therapeutics in Tumor-Bearing Mice. Cancers. 13(5). 957–957. 60 indexed citations
4.
Choi, Won‐Il, Bu‐Nam Jeon, Dong‐In Koh, et al.. (2019). Zbtb7c is a critical gluconeogenic transcription factor that induces glucose-6-phosphatase and phosphoenylpyruvate carboxykinase 1 genes expression during mice fasting. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1862(6). 643–656. 14 indexed citations
5.
Kim, Hye Ran, Kyung-Sik Lee, Yoo-Jin Park, et al.. (2018). T cell microvilli constitute immunological synaptosomes that carry messages to antigen-presenting cells. Nature Communications. 9(1). 3630–3630. 89 indexed citations
6.
Koh, Dong‐In, Jin Young Kim, Masahiko Hatano, et al.. (2018). Reciprocal negative regulation between the tumor suppressor protein p53 and B cell CLL/lymphoma 6 (BCL6) via control of caspase-1 expression. Journal of Biological Chemistry. 294(1). 299–313. 12 indexed citations
7.
Koh, Dong‐In, et al.. (2016). Role of MIZ-1 in AMELX gene expression. Biochemistry and Biophysics Reports. 8. 340–345. 2 indexed citations
8.
Jeon, Bu‐Nam, Min-Kyeong Kim, Won‐Il Choi, et al.. (2016). Zbtb7c is a molecular ‘off’ and ‘on’ switch of Mmp gene transcription. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1859(11). 1429–1439. 9 indexed citations
9.
Koh, Dong‐In, et al.. (2015). Transcriptional activation of APAF1 by KAISO (ZBTB33) and p53 is attenuated by RelA/p65. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1849(9). 1170–1178. 13 indexed citations
10.
Jeon, Bu‐Nam, Minkyeong Kim, Min‐Young Kim, et al.. (2014). Two ZNF509 (ZBTB49) isoforms induce cell-cycle arrest by activating transcription of p21/CDKN1A and RB upon exposure to genotoxic stress. Nucleic Acids Research. 42(18). 11447–11461. 18 indexed citations
11.
12.
Choi, Won‐Il, Bu‐Nam Jeon, Dong‐In Koh, et al.. (2014). Human Krüppel-related 3 (HKR3) Is a Novel Transcription Activator of Alternate Reading Frame (ARF) Gene. Journal of Biological Chemistry. 289(7). 4018–4031. 8 indexed citations
13.
14.
Jeon, Bu‐Nam, Kim Ys, Won‐Il Choi, et al.. (2012). Kr-pok increases FASN expression by modulating the DNA binding of SREBP-1c and Sp1 at the proximal promoter. Journal of Lipid Research. 53(4). 755–766. 29 indexed citations
15.
Jeon, Bu‐Nam, et al.. (2011). Bacille Calmette Guérin (BCG) can induce Kawasaki disease-like features in programmed death-1 (PD-1) gene knockout mice.. PubMed. 29(4). 743–50. 13 indexed citations
16.
Jeon, Bu‐Nam, et al.. (2011). The Pleiohomeotic Functions as a Negative Regulator of Drosophila even-skipped Gene during Embryogenesis. Molecules and Cells. 32(6). 549–554. 3 indexed citations
17.
Jeon, Bu‐Nam, Won‐Il Choi, A‐Rum Yoon, et al.. (2009). ZBTB2, a Novel Master Regulator of the p53 Pathway. Journal of Biological Chemistry. 284(27). 17935–17946. 48 indexed citations
18.
Koh, Dong‐In, Won‐Il Choi, Bu‐Nam Jeon, et al.. (2009). A Novel POK Family Transcription Factor, ZBTB5, Represses Transcription of p21CIP1 Gene. Journal of Biological Chemistry. 284(30). 19856–19866. 25 indexed citations
19.
Jeon, Bu‐Nam, Jung‐Yoon Yoo, Won‐Il Choi, et al.. (2008). Proto-oncogene FBI-1 (Pokemon/ZBTB7A) Represses Transcription of the Tumor Suppressor Rb Gene via Binding Competition with Sp1 and Recruitment of Co-repressors. Journal of Biological Chemistry. 283(48). 33199–33210. 83 indexed citations
20.
Jeon, Bu‐Nam, et al.. (2007). Regulation of Pokemon 1 Activity by Sumoylation. Cellular Physiology and Biochemistry. 20(1-4). 167–180. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026